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Dual effect of lysophosphatidic acid on proliferation of glomerular
mesangial cells. Among the variety of factors able to contribute to
mesangial hypertrophy by altering mesangial cell growth, lysophosphatidic
acid (LPA) is the focus of increasing attention. It is produced in plasma
following platelet activation, as well as by mesangial cells stimulated by
secretory phospholipase A2. As mitogenic/antimitogenic properties of
LPA are already described in a variety of cells, knowledge of its specific
actions on mesangial cells is of potential interest regarding the pathophys-
iology of glomerulus damage in situ. We tested the effect of LPA on
cultured rat mesangial cell growth. At 10 to 20 tiM, LPA stimulated
thymidine incorporation as well as phosphorylation of mitogen-activated
protein kinases (MAP-kinases) p42-p44 in dose- and time-dependent
manner, which demonstrated a positive effect on cell proliferation.
However, higher concentrations of LPA (100 jiM) were unable to stimu-
late thymidine incorporation and partly inhibited the proliferative effect as
well as p42-p44 phosphorylation evoked by serum. Finally, whereas
lysophosphatidylcholine (10 to 20 jiM) was lytic for mesangial cells, no cell
lysis could be detected at the highest concentrations of LPA. Taken
together, these results suggest that LPA exerts a dual effect on mesangial
cell proliferation, which could be due to activation of distinct specific
signaling pathways, in dose-dependent fashion. Specific actions of LPA
able to modify mesangial cell proliferation in a positive or negative
manner are also likely to influence the pathophysiological processes
involved in the progression of glomerulosclerosis in the kidney.
Mesangial expansion and mesangial cell proliferation usually
precede the development of glomerular sclerosis [1]. A number of
factors (growth factors, cytokines or vasoactive peptides) alter
mesangial cell growth in vitro, which may contribute to mesangial
hypertrophy in vivo [2—7]. Among the variety of cellular lipids,
lysophosphatidic acid (LPA), a structurally simple phospholipid
(Fig. 1), is the focus of increasing attention [8, 9]. LPA rapidly
produced in the plasma following activation of platelets exerts
growth-factor-like activity [9, 101, and was recently reported to
evoke contractility and Ca2 mobilization in mesangial cells [11].
In addition, LPA is produced by mesangial cells stimulated by
exogenous group II phospholipase A2 [12], this secretory enzyme
being considered to be crucial in the initiation and propagation of
inflammation by mesangial cells [13, 14]. In a recent hypothesis,
we suggested that LPA can be generated upon hydrolysis of
phosphatidic acid (note structure in Fig. 1) by secretory phospho-
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lipase A2, via a specific mechanism involving membrane shedding,
which points to possible local production of LPA in the vicinity of
cells during inflammatory processes [15].
Because of the potential roles of this lipid mediator during
mesangial expansion in chronic and progressive glomerulonephri-
tis, we tested the effect of LPA on cultured mesangial cell growth.
In the present study we demonstrate that LPA stimulates mesan-
gial cell proliferation, which is associated with activation of
mitogen-activated protein kinases (MAP kinases) p42 and p44.
Moreover, these results are consistent with a dual effect of LPA
on mesangial cells, higher concentrations of LPA exhibiting an
antagonistic effect on proliferation.
Methods
Materials
Anti-MAP kinase antibody and CDP-Star chemiluminescent
reagent were from New England Biolabs Ltd. (Beverly, MA,
USA). [3H]thymidine (20 Ci/mmol) was from Du Pont NEN (Les
Ulis, France). Protein molecular mass standards were from Phar-
macia (Uppsala, Sweden). Fetal calf serum (FCS) was from Gibco
BRL (Paisley, Scotland, UK). Multiwells and culture flasks were
from Falcon Plastic (Paisley, Scotland, UK). PVDF membrane
was from Bio-Rad (Hercules, CA, USA). Lysophosphatidic acid,
lysophosphatidylcholine, lysophosphatidylinositol, insulin, D-va-
line medium, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium
bromide (MTT), RPMI 1640, trypsin, collagenase, in vitro toxi-
cology assay kit (lactate dehydrogenase based) and other reagents
were from Sigma Chemical Co. (St. Louis, MO, USA).
Isolation of rat renal glomeruli and culture of mesangial cells
Renal glomeruli were isolated from kidneys of two months old
male Wistar rats weighing 150 to 200 g. Most of the procedure was
adapted from Striker and Striker [16] as described [17]. Briefly,
the kidneys were removed from their capsule and the cortex
fragments (3 to 4 mm3) were submitted to four repeated enzy-
matic digestions with collagenase at 37°C in phosphate-buffered
saline (PBS) solution. The glomeruli, purified by successive
mechanical sieving (100, 80 and 60 jim) were retained on the 80
and 60 jim pore stainless steal sieves. Glomerular mesangial cells
were obtained from glomerulus preparations and cultured under
standardized conditions at 37°C in a humidified 5% (vol/vol) CO2
incubator, in base medium supplemented with 20% (vol/vol)
decomplemented FCS plus 100 U/mI penicillin, 100 jig/mI strep-
tomycin, and 2 m'vi glutamine. Base medium was RPMI 1640.
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Fig. 1. Compared structures of phosphatidic and lysophosphatidic acids.
Upon reaching confluence, cells were subcultured or harvested by
using 0.125% (wtlvol) trypsin. Primary cultures were passaged
after three to four weeks. In order to eliminate contamination by
either epithelial or endothelial cells, all experiments were per-
formed between the 15th and 25th passages. Mesangial cells were
characterized by their morphological appearance in phase con-
trast and their biological and biochemical properties as described
[171: (1) positive staining with antibodies to myosin or vimentin,
and negative staining with antibodies to factor VIII and to
cytokeratins by standard immunofluorescence; (2) the ability to
contract in response to iO M angiotensin II; (3) an ability to
grow in selective D-valine containing medium. Before these
experiments, cells were made quiescent by serum starvation for 36
hours in RPM! as above with 0.5% (vol/vol) FCS.
[3H]thymidine incorporation
Preconfluent quiescent mesangial cells cultured in 24-well
tissue culture dishes were incubated with the growth stimulus to
be tested. At the required time, [3H]thymidine (0.25 mCi/ml) was
added and the incubation continued for additional four hours.
Cells were washed with PBS, lysed and precipitated with 5%
(wt/vol) trichioroacetic acid (TCA). Precipitates were washed with
absolute ethanol and then air dried. The TCA-precipitable mate-
rial was dissolved in 0.5 M NaOH and the radioactivity was
measured in triplicate with a liquid scintillation counter. The data
were expressed as ratio (fold stimulation) of the mean control
value.
MTT assay and cell lysis assay
Preconfluent quiescent mesangial cells were cultured in 12 well
dishes and treated by the growth stimulus as indicated. The MIT
assay was performed as described [18], in triplicate with 0D570
read on a spectrophotometer (Beckman Instruments Inc., Fuller-
ton, CA, USA). Matching triplicate dishes were trypsinized and
counted using a Coulter counter. The data were expressed as as
ratio (fold stimulation) of the mean control value. For the cell
lysis assay, lactate dehydrogenase activity was determined in both
supernatants and cells using a kit from Sigma. The percentage of
lysis was calculated from the ratio of enzyme activity in superna-
tant to enzyme activity in supernatant plus cells.
MAP-kinase phosphoiylation assay
Phosphorylation of p42 and p44 MAP kinases (ERK1 and
ERK2) was tested by means of an antibody raised against
phosphorylated MAP kinases, which specifically detects p42 and
p44 phosphorylated on the residue homologous of tyrosine 204 in
p42 [19]. Briefly, after incubation cells were washed twice with
PBS, then lysed with sodium dodecyl sulfate (SDS) sample buffer
containing 62 mivi Tris-HC1 (pH 6.8), 2% (wt/vol) SDS, 10%
(vol/vol) glycerol, 50 mivi dithiothreitol, and 0.1% (wt/vol) bromo-
phenol blue. Homogenates were sonicated 10 seconds, clarified at
13,000 rpm two minutes, boiled two minutes, run onto SDS-
—
PAGE, then electrotransferred to PVDF membrane. Membrane
was blocked one hour by PBS buffer with 5% (wt/vol) nonfat dry
milk, then incubated overnight with anti-phosphorylated MAP
kinase antibody (dilution 1/1000), and another hour with alkaline
phosphatase-conjugated anti-rabbit secondary antibody (dilution
1/4000). Detection was performed by means of CDP-Star chemi-
luminescent reagent. Each observation was confirmed at least
twice.
Statistics
Results are expressed as mean SEM (N = 3) and are
representative of two to six experiments, as indicated in the
legends. Comparisons were made using Student's t-test; signifi-
cance of results was determined by P < 0.05,
Results
Proliferation of mesangial cells under the effect of LPA
As shown in Figure 2A, incubation of mesangial cells with LPA
during 24 hours resulted in a dose-dependent increase of thymi-
dine incorporation, which was maximal at 20 I.LM LPA. Under
these conditions, the stimulation ratio was 1.91 0.18 (mean
SEM, 7 independent experiments, P < 0.01). The full effect,
however, was limited to LPA concentrations within 10 to 20 sM,
stimulation of thymidine incorporation being not significant at 100
LM LPA. Under the latter conditions, whether LPA was neither
lytic nor toxic for the cells was verified by Trypan blue exclusion.
The effect of 20 fM LPA on thymidine incorporation was detect-
able at 12 hours, with a peak around 24 hours, and was kinetically
comparable to that obtained with 5% FCS (data not shown).
Stimulation of MIT conversion by LPA paralleled the effect on
thymidine incorporation (Fig. 2B). Determination of cell number
confirmed that low concentrations of LPA exerted a stimulatory
effect on cell proliferation (Fig. 2C).
Effect of LPA on MAP-kinase tyrosine phosphoiylation
To correlate the precedent effects of LPA on cell proliferation
with biochemical events occurring downstream of putative LPA
receptors, we tested the phosphorylation of p42 and p44 MAP
kinases in stimulated cells, At 20 M, LPA increased p42-p44
phosphorylation (Fig. 3). From quantitative data shown in Figure
4A, it appeared that LPA-induced phosphorylation of p42 and
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Fig. 2. Effect of LPA on mesangial cell proliferation. Subconfluent quies-
cent cells (15th to 20th passages) were incubated during 24 hours with
various concentrations of LPA (5 to 100 rM) or vehicle as a control (con).
Cells were then incubated with [3Hlthymidine (A), or MTT (B), or they
were trypsinized for counting (C). Results (means 5EM) are triplicate
determinations from one experiment representative of 6, 2 and 3 inde-
pendent experiments for A, B and C, respectively. *p < 0.05; ** < 0.01.
p44 paralleled the dose-dependent effect of LPA on thymidine
incorporation, with a maximum at 10 to 20 /.LM LPA, and a
decrease above. Cells stimulated by LPA exhibited a two-wave
profile of MAP-kinase phosphorylation, a first peak appearing at
20 to 30 minutes, and a second peak, moderate and more
sustained, occurring at 90 to 120 minutes (Fig. 4B). Furthermore,
phosphorylation remained slightly detectable at 12 hours (not
shown).
Inhibition of FCS-stimulated mesangial cell proliferation by high
concentrations of LPA
Considering the slight effect of 100 /.tM LPA on mesangial cell
proliferation, and since antimitogenic effects of LPA are also
known, we tested the hypothesis of an inhibitory effect of LPA by
incubating the cells with 5% (vol/vol) FCS in the presence of 100
1LM LPA. FCS alone promoted a 7.5-fold stimulation of thymidine
incorporation, which was decreased by 54% upon simultaneous
p42 C LPA
Fig. 3. Effrcr of LPA on p42 and p44 MAP-kinase tyrosinephosphoiylation.
Subconfluent quiescent cells (20th to 25th passages) were incubated
during 10 minutes with vehicle only (C) or LPA (20 tiM), run onto
SDS-PAGE, electrotransferred and detected with anti-phosphorylated
MAP-kinase antibody. Molecular mass standard positions (kDa) are
indicated on the left. On the left lane, a standard of phosphorylated p42
was deposited onto the gel.
addition of 100 j.M LPA (Fig. 5A). In parallel, incubation of
mesangial cells with 100 J.LM LPA and 5% FCS resulted in a
decrease of the effect of FCS on MAP-kinase phosphorylation
(Fig. 5B).
Determination of cell lysis in mesangial cells stimulated with LPA
To exclude the possibility that high concentrations of LPA
might be deleterious to the cells owing to a detergent-like effect,
lactate dehydrogenase activity was determined in supernatants of
cells incubated for 24 hours with various concentrations of LPA.
As shown in Table 1, no significant cell lysis could be detected
even at 100 /.LM LPA. In fact, at all concentrations tested LPA
reduced the release of lactate dehydrogenase occurring from
mesangial cells incubated in a medium containing 0.5% serum. In
contrast, lysophosphatidylcholine (LPC) exerted a lytic effect,
which attained 43.6% at only 20 .tM. In additional experiments
dealing with shorter incubation times (1 hr), 50 JiM LPC induced
73% lysis, whereas lysophosphatidylinositol was still more effec-
tive (61% and 85% lysis at 20 and 50 jiM, respectively, data not
shown).
Discussion
As a main conclusion of this study, a mitogenic effect of low
concentrations of LPA could be demonstrated in cultured rat
mesangial cells. In a study centered on the effects of phosphatidic
acid, a similar action of LPA was observed in human mesangial
cells, however, dose dependence was not investigated [20]. In
fibroblasts, the intensity of the proliferative effect of LPA can
reach the level attained with the serum itself [21]. In mesangial
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Fig. 4. Time course and dose response of the effect of LPA on p42 and p44
MAP-kinase tyrosinephosphotylation. Subconfluent quiescent cells (20th to
25th passages) were incubated with LPA. A. Dose response: cells were
incubated for 15 minutes with indicated concentrations of LPA. B. Time
course: cells were incubated for indicated times with 20 jrM LPA. Upper
part, SDS-PAGE, electrotransfer and detection with anti phosphorylated
MAP-kinase antibody and chemiluminescence. Lower part, quantitation
of p42 and p44 in data above after scanning (means SCM, 3 experi-
ments). Abbreviation Con is controls without LPA. *p < 0.05; ** < 0.01.
B
Fig. 5. Effect of LPA on FCS stimulated f3H]thymidine incotporation and
p4.2-p44 MAP-kinase tyrosine phosphoiylation. A. Subconfluent quiescent
cells (20th to 25th passages) were incubated for six hours with vehicle only
(CONT), with 5% (vol/vol) FCS, with 100 /LM LPA, or with both 5% FCS
and 100 jLM LPA, and then incubated for one hour with [3Hlthymidine.
Data are means SCM of triplicate determinations and are representative
of two independent experiments. < 0.05, comparison with FCS alone.
B. Subconfluent quiescent cells were incubated for 15 minutes under
conditions described in A. Upper part, SDS-PAGE, electrotransfer and
detection with anti-phosphorylated MAP-kinase antibody and chemilumi-
nescence. Lower part, quantitation of p42 and p44 in data above after
scanning.
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cells, the effect of LPA regarding thymidine incorporation was
lower than that obtained with FCS, and was in the same range as
that observed with other growth factors, like vasoactive peptides
[4—6]. In many cases, these factors induce more hypertrophy than
hyperplasia, or act as comitogens only [5—7, 22]. In addition to a
stimulation of thymidine incorporation, LPA was responsible in
mesangial cells for an increase of both MTTconversion and of cell
number. In our opinion, this demonstrates that low concentra-
tions of LPA alone exert an effective stimulatory effect on
mesangial cell proliferation, suggesting a role of LPA as a
progression factor, as has been suggested for insulin, platelet-
derived growth factor, or insulin-like growth factor 1 [22, 23]. This
is in accordance with data observed in fibroblasts, where LPA
appears as a complete substitute to the stimulatory effect of
serum, and is considered as a progression factor [21, 24]. Con-
versely, no major phenotypic modification suggesting hypertrophy
was noticed during 48 hours of incubation with low doses of LPA.
A second conclusion concerns the mechanism of the mitogenic
effect of LPA. This seems to involve phosphorylation of p42-p44
MAP kinases at tyrosine 204, which is known to be essential for
the activation of MAP kinases [19]. Indeed, we could verify that
LPA stimulated the myelin basic protein kinase activity of mes-
angial cells in a manner similar to that described for platelet-
derived growth factor and angiotensin II (data not shown) [22].
Growth factor activation of p42-p44, when associated with effec-
tive proliferative responses, usually comprises a sustained phase
a a
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Table 1. Determination of cell lysis in mesangial cells incubated with
lysophospholipids
Lysophospholipid Cell lysis % P
None 17.0 1.9
LPA 20 M 10.8 0.6 <0.05
LPA 50 j.M 10.6 0.2 < 0.05a
LPA 100 M 11.3 1.4 NS
LPC 10 M
LPC2O f.tM
25.5 4.0
43.6 2.3
< <
< 0.001a; < 00fflb
Subconfluent quiescent cells (20 to 25 passages) were incubated during
24 hours with various concentrations of LPA or LPC or with vehicle. Cell
lysis was determined by measuring lactate dehydrogenase activity in the
supernatants. Data are means SEM (3 different incubations). Abbrevia-
tions are LPC, lysophosphatidylcholine; NS, nonsignificant.
Compared to controls (no lysophospholipid)
Compared to LPA 20 .LM
during biphasic kinetic activation of MAP kinases [25, 261. This
fact, which was also observed with mesangial cells as a require-
ment for effective hyperplasic effects of various agonists [22], was
observed herein with LPA. Activation of p42-p44 MAP kinases
involves the sequential upstream stimulation of ras and raf, and
has been recognized as an essential step required for cell division
entry [25—291. This pathway is activated by growth factors acting
on membrane receptors with protein tyrosine kinase activity by
mechanisms now clearly established [27—29]. In the case of
agonists using receptors coupled to heterotrimeric G-proteins,
such as LPA, the intermediate steps between receptor and ras are
still unknown, although increasing evidence underlines a major
role of protein tyrosine kinases acting downstream of the 3y-
subunits of Gi [30—34]. From the parallelism between the biolog-
ical effects reported herein and the phosphorylation level of
p42-p44 MAP kinases, it thus appears rather obvious that similar
if not identical transduction pathways could be used in mesangial
cells by LPA under conditions leading to an increased prolifera-
tion.
The action of LPA on mesangial cells is in fact more complex,
since the specificity of its mitogenic effect depends on the
concentration used. Indeed, at 100 ILM LPA was far less stimula-
tory, and was even able to partly inhibit the full effect of serum
regarding thymidine incorporation as well as MAP-kinase phos-
phorylation. Since LPA did not appear to be toxic under these
conditions, as shown by the absence of lysis, these data suggest
that in mesangial cells the ultimate effect of high doses of LPA
may be the sum of stimulatory and inhibitory actions. An antimi-
togenic effect of LPA was previously described in other cells [35,
36]. Especially in MDCK cells, LPA possesses mitogenic-antimi-
togenic effects in a dose-dependent manner [35],
Interestingly, the lack of mitogenic effects or inhibition by LPA
of serum-stimulated proliferation were parallel to the variations in
the level of p42-p44 phosphorylatioti. This gives further support to
the view of a strong linkage between activation of the MAP-kinase
pathway and stimulation of proliferation. Further studies will be
necessary to clarify how LPA at high concentrations inhibits
mesangial cell proliferation by interfering with signal transduction
probably upstream of p42-p44 MAP kinases. The duality of LPA
effect could be due to the presence of more than one type of
receptors with different affinity for the phospholipid mediator
[37]. For this or other reasons, LPA could activate additional
signaling pathways, involving, for instance, Jun kinase (JNK). This
cascade is stimulated by ceramides in inesangial cells, and it exerts
opposing action on p42-p44 MAP kinases, leading to antiprolif-
erative effects [28, 38]. This family of stress-activated kinases, as
well as another family of p38/HOG1 kinases, seem able to induce
apoptosis when activated by cytokines. It is thus tempting to
suggest that mitogenic and antimitogenic effects of LPA respon-
sible for apoptosis in a dose-dependent manner could finally
positively or negatively influence renal scarring subsequent to
glomerular inflammation [391. Regarding the potential role of
LPA in pathophysiology, complete knowledge of the action of this
lipid mediator in mesangial cells seems of primary interest for a
better understanding of the mechanisms underlying the progres-
sion of glomerulosclerosis.
Finally, it is interesting to compare the proliferative effect of
LPA described herein to that exerted on mesangial cells by its
putative precursor phosphatidic acid [20]. Although both com-
pounds also act as growth factors on fibroblasts [241, the func-
tional relationship between the two phospholipids is still unclear.
Indeed, phosphatidic acid is known as an intracellular compound,
whereas the extracellular actions of LPA are well documented [8,
91. Since mesangial cells synthesize and secrete type II phospho-
lipase A2 under certain conditions, it is tempting to suggest that
the extracellular effects of phosphatidic acid might involve its
deacylation to LPA. However, internalization of phosphatidic acid
resulting in an increased local concentration might also be in-
volved in the mechanism of its biological effect, as suggested by
Kriauss, Jaffer and Abboud [201. Further studies are required to
quantitate the amounts of both phosphatidic acid and LPA
produced by mesangial cells. This will be particularly important to
assess the potential role of LPA as an autocrine factor regulating
mesangial cell growth.
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